EpiXact® Helps Stop a Carbapenem-Resistant Acinetobacter baumannii Outbreak in a Burn ICU
February 28 2020
Research published in Infection Control and Hospital Epidemiology details use of patient and environmental whole genome sequencing to stop a CRAB outbreak
Read More
EpiXact® Used to Identify Drug-Resistant E. coli Transmitted by Fecal Microbiota Transplant
November 6 2019
EpiXact confirms cause of first patient death reported from an FMT procedure in research published in the New England Journal of Medicine
Read More
DZD Presents at Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
July 10 2019
CEO Jong Lee delivers DZD technology overview to Council
Read More
DZD Awarded SBIR Phase 1 Grant from NIH
July 10 2019
Funding supports development of algorithm for automated analysis of DNA sequencing data for outbreak detection
Read More
DZD Launches Rapid Sequencing Service for Healthcare-Associated Infection Investigations
June 3 2019
EpiXact brings the precision of DNA sequencing to hospital infection control to enhance patient safety
Read More
Day Zero Diagnostics Presents at the Future of Individualized Medicine Conference
March 15 2019
Video: CTO Miriam Huntley discusses how to modernize infectious disease diagnostics with bacterial sequencing
Read More